Peritoneal Transport With a New Bicarbonate-based Peritoneal Dialysis Solution Compared to Conventional Solution.
1 other identifier
interventional
7
1 country
1
Brief Summary
Cross-over study. Patients treated with peritoneal dialysis are investigated twice with a single 4h dwell study: once with Bicarbonate-Lactate solution as buffer (Physioneal TM) and once with conventional lactate PD solution (Dianeal TM). Radioidinated human serum albumin is used as a volume marker to assess ultrafiltration and frequent dialysis and blood sampling to assess peritneal transport of solutes and pH changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 1997
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 1997
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 1997
CompletedStudy Completion
Last participant's last visit for all outcomes
November 13, 1997
CompletedFirst Submitted
Initial submission to the registry
May 12, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedJune 4, 2026
May 1, 2026
2 months
May 12, 2026
June 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in net ultrafiltration (ml)
Assessment of fluid transport during a PD dwell. Intraperitoenal volume changes during the 4 hour dwells will be assesed from dilution of the added volume marker with correction for absorption of the marker. Amount of marker remaining in the drained fluid after four hours will be subratcted from the initial added amount to calculate amount of marker absorbed during the dwell. Residual volumes before and after the dwell can also be calculated from dilution of the marker. This makes it possible to calculate the intraperitoneal volume of time curve during the dwell and net ultrafiltration (=net fluid removal). To simplify, the intraperitoneal volume (ml) at 240 minutes of the dwell minus the intraperitoneal volume after infusion of the dialysis fluid.
4 hours
Secondary Outcomes (3)
Changes to acid-base homeostasis
4 hours
Differences in small solute transport
4 hours
Differences in protein transport
4 hours
Study Arms (2)
Bicarbonate lactate solution investigatd first
EXPERIMENTALThe patients were studied with the bicarbonate-lactate solution the first study day and with conventional lactate.based solution on a later day.
Lactate solution investigated first
EXPERIMENTALThe patients were studied with the conventional lactate.based solution the first study day and with bicarbonate-lactate solution on a later day.
Interventions
All patients were studied twice with a 4-h dwell study (one peritoneal dialysis dwell) about 7 days apart. The two arms represent different order of the used periteonal dialysis fluid for the two dwell studies.
Eligibility Criteria
You may qualify if:
- patient treated with peritoneal dialysis in a clinically stable condition
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Research unit, renal medicine
Stockholm, S-141 86, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor, MD, PhD
Study Record Dates
First Submitted
May 12, 2026
First Posted
June 2, 2026
Study Start
September 9, 1997
Primary Completion
November 13, 1997
Study Completion
November 13, 1997
Last Updated
June 4, 2026
Record last verified: 2026-05